Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship?

Vasiliki Katsi1, Ioannis Felekos, Stamatios Skevofilax

  • 1From the *1st Cardiology Department, Hippokration Hospital/Athens Medical School, Athens, Greece; †Cardiology Department Hippokration Hospital, Athens, Greece; and ‡General Hospital, Chios, Greece.

Cardiology in Review
|June 14, 2014
PubMed

Insights

Hepatitis C virus (HCV) infection is linked to increased cardiovascular disease risk factors like hypertension and diabetes. This review explores the connection between chronic hepatitis C (CHC) and heart conditions, including cardiomyopathy.

Area of Science:

  • Hepatology
  • Cardiology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) is a primary cause of liver disease, including hepatocellular carcinoma and cirrhosis.
  • Emerging evidence suggests a significant association between chronic hepatitis C (CHC) and cardiovascular complications.
  • CHC may contribute to metabolic dysfunctions and hepatic failure, impacting systemic health.

Purpose of the Study:

  • To review the relationship between HCV infection and cardiac disease.
  • To highlight potential mechanisms linking HCV to heart conditions.
  • To summarize population-based data on CHC and cardiovascular outcomes.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Analysis of epidemiological data on HCV patients and cardiovascular events.
  • Exploration of proposed pathophysiological pathways.

Main Results:

  • CHC is associated with major cardiovascular disease risk factors, including hypertension, insulin resistance, diabetes mellitus, and atherosclerosis.
  • Evidence suggests CHC may be an independent risk factor for atherosclerotic heart disease and cardiomyopathy.
  • Population data supports a link between HCV infection and increased cardiac morbidity.

Conclusions:

  • HCV infection is associated with a higher prevalence of cardiovascular risk factors.
  • CHC should be considered a significant factor in the development of heart disease.
  • Further research into the mechanisms and clinical management of cardiac manifestations in CHC is warranted.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
80
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
380
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
34
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
26
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271